A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors
Clinical trial NCT05125523 · UNKNOWN
Trial details
- NCT number
- NCT05125523
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2024-06-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.